These contradictory results led some researchers to believe that butyrate may contribute to the obesogenic phenotype
Reyes CD, Petrie TA, Burns KL, Schwartz Z, Garcia AJ
Other health conditions may also make some people less likely to see significant weight loss on GLP-1s
With GLP-1 usage increasing , companies are investing in structured weight management programs to support lasting results, improve overall employee health, and potentially reduce long-term healthcare costs
These fatty acids enter the bloodstream and become available for oxidation
While unlikely to cause false positives in standard drug tests, vigilance and open communication with healthcare providers ensure accurate test results and prevent complications